Clinical challenges: Myeloma and concomitant type 2 diabetes.
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematological cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.
Department of Endocrinology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Mohamed Ahmed
MA
Ali
Princess Noorah Oncology Centre, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.
Yasar A
YA
Ahmed
Haematology, Princes Sultan Military Medical City, Riyadh, Saudi Arabia.
Abubaker
A
Ibrahim
Diabetes mellitus; glucose; hyperglycemia; multiple myeloma